Serum theophylline and menstrual asthma attack [16]

Lancet

Volumn 350, Issue 9085, 1997, Pages 1178-

  Ohrui, T ^a   Funayama, T ^a   Sekizawa, K ^a   Sasaki, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CONJUGATED ESTROGEN; CORTICOSTEROID; ESTRADIOL; ESTROGEN; GESTAGEN; PLANOVAR; PROGESTERONE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; ASTHMA; CASE REPORT; DETERIORATION; DRUG CLEARANCE; DRUG MEGADOSE; DRUG MIXTURE; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LETTER; LUTEAL INSUFFICIENCY; LUTEAL PHASE; MENSTRUATION; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PUBERTY; THEOPHYLLINE BLOOD LEVEL;

EID: 0030659602     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63825-1     Document Type: Letter

References (2)

1. N Macready Menstrual variations influence theophylline clearance Lancet 350 1997 644
2. K Nagata K Ishitobi Y Yamamoto Increased theophylline metabolism in the menstrual phase of healthy women J Allergy Clin Immunol 100 1997 39 43